Burjeel Holdings to Revolutionize Cancer Care in MENA with 90% Cheaper CAR-T Therapy
In a groundbreaking move set to transform cancer treatment access across MENA, Burjeel Holdings has partnered with U.S.-based non-profit Caring Cross to locally manufacture CAR-T cell therapies at up to 90% less than current international costs. Caring Cross will support Burjeel Holdings with the necessary technology, materials, and specialized training to establish a local ecosystem for manufacturing CAR-T therapies, as well as providing lentiviral vectors essential for clinical development. The collaboration was announced at Abu Dhabi Global Health Week in the presence of Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings.
CAR-T therapies, which reprogram a patient's immune cells to attack cancer cells, have shown remarkable success in treating certain blood cancers like leukemia and lymphoma. However, with costs ranging from US$350,000 to over $1 million in global markets, access remains severely restricted. The partnership seeks to dismantle this barrier by enabling the production of CAR-T therapies at a fraction of the current price, making these treatments accessible to a vastly broader patient population in MENA and beyond.
Enhancing Access to Life-Saving Cancer Care
The collaboration will position Burjeel Holdings as a regional hub for advanced cell and gene therapies. By enabling local, point-of-care production of patient-specific therapies, the initiative will expand the reach of these therapies to underserved populations across the MENA region. The first phase of the program will focus on CAR-T therapies for leukemia and lymphoma, with plans to explore treatments for other diseases, including HIV, in the future.
'We are honored to partner with Caring Cross, whose expertise in CAR-T cell therapy production technology will enable us to provide affordable, life-saving treatments to our communities and beyond. This partnership is a pivotal step in our commitment to advancing medical innovation and expanding access to critical healthcare services,' said John Sunil, Group CEO of Burjeel Holdings.
'We are excited to partner with Burjeel Holdings to improve access to CAR-T cell and other ATMPs for patients across their hospital networks in the MENA region,' said Boro Dropuli?, Executive Director of Caring Cross. 'This collaboration advances our mission to make these groundbreaking treatments accessible and affordable around the world. By combining our innovative technologies with Burjeel Holdings hospital network and infrastructure, we intend to significantly improve patient access with a sustainable and cost-effective model.'
Building Local Capabilities and Expanding Impact
This initiative reflects Burjeel Holdings' broader mission to expand access to high-quality healthcare in regions that need it most. The partnership will focus on training and developing local healthcare providers, ensuring the sustainable and scalable delivery of CAR-T therapies across MENA, India, and globally.
'Our collaboration is operating at the cutting edge of medical innovation, opening doors to biological therapies not just in MENA, but also in emerging markets like India and other parts of Asia. This is a monumental stride in enhancing access to cancer treatments and addressing the escalating need for advanced healthcare globally,' said Dr. Ajlan Al Zaki, Director of the Hematology Oncology & Cellular Therapy Center at Burjeel Hospital Abu Dhabi.
This partnership reinforces Burjeel Holdings' commitment to transforming the healthcare landscape in MENA and beyond, offering hope and tangible solutions to millions of patients who previously lacked access to life-saving treatments.
Prev Post
Salik To Launch Automatic Parking At 18 Dubai Locations
Comments are closed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
9 hours ago
- Zawya
Longer-dated yields rise, Fed policy in focus
Longer-dated U.S. Treasury yields rose on Friday as traders evaluated how many times the Federal Reserve could cut rates this year, while increases in European government bond yields also dragged U.S. yields higher. The Fed is seen as being all but certain to cut rates in September as the labor market and other economic indicators point to a slowing economy. So far tariffs have not passed through to consumer price inflation, which boosts the chances of a cut next month. Hotter-than-expected producer price inflation on Thursday, however, tempered expectations that the U.S. central bank will undertake a larger-than-typical 50 basis points move. 'The yield curve keeps steepening. I think that's a function of the Fed rate cuts that are coming in September,' said Tom di Galoma, managing director at Mischler Financial Group. 'I don't think they're going to do 50 in September, I think 25 is probably more logical at this point, just given the fact that Powell seems to be reluctant to go at all.' Fed Chair Jerome Powell has expressed reluctance to cut rates as he anticipates U.S. President Donald Trump's tariff policies will increase inflation this summer. Investors will focus on whether Powell pushes back against market pricing of rate cuts at the U.S. central bank's annual economic policy symposium in Jackson Hole, Wyoming, next week. Yields briefly rose after data on Friday showed U.S. retail sales increased solidly in July, boosted by strong demand for motor vehicles as well as promotions by Amazon and Walmart. The 2-year note yield, which typically moves in step with Fed interest rate expectations, was last down 0.9 basis points on the day at 3.73%. The yield on benchmark U.S. 10-year notes rose 0.9 basis points to 4.302%. The yield curve between two-year and 10-year notes steepened by around 2 basis points to 57.4 basis points, the steepest since July 16. Longer-dated yields are being pulled higher in line with increases in European government debt yields. 'Curves keep steepening there and they just keep selling off,' said di Galoma. German 10-year yields reached 2.78% on Friday, the highest since March 27. German 30-year yields reached 3.354%, the highest since 2011. Analysts at ING said on Friday that implied volatility increases in the very long end of the euro swap curve are likely due to an upcoming Dutch pension transition. 'We are seeing this behaviour in the US where the fiscal deficit is worrying investors, but in the euro space the 30Y swap spread has remained fairly constant the past months. We therefore see the anticipated Dutch pension funds' rotation away from longer-dated swaps as a potential driver behind recent moves,' they said. Traders are also focused on talks to end the Russian war in Ukraine. Trump and Russian President Vladimir Putin meet at a Cold War-era air force base in Alaska on Friday to discuss a ceasefire deal for Ukraine that the U.S. sees as a possible way to end the deadliest war in Europe since World War Two. (Reporting by Karen Brettell in New York; Editing by Nia Williams)
Zawya
9 hours ago
- Zawya
US consumer sentiment weakens in August; inflation expectations rise
U.S. consumer sentiment softened in August as households anticipated higher goods prices because of import tariffs. The University of Michigan's Surveys of Consumers on Friday said its Consumer Sentiment Index dropped to 58.6 this month from a final reading of 61.7 in July. Economists polled by Reuters had forecast the index would increase to 62.0. "This deterioration largely stems from rising worries about inflation," Joanne Hsu, the director of the Surveys of Consumers, said in a statement. "Buying conditions for durables plunged 14%, its lowest reading in a year, on the basis of high prices." Consumers' 12-month inflation expectations increased to 4.9% this month from 4.5% in July. Long-run inflation expectations rose to 3.9% from 3.4% last month. (Reporting by Lucia Mutikani; Editing by Paul Simao)
Zawya
13 hours ago
- Zawya
Gold heads for weekly decline as US price data dims hopes of big Fed cut
Gold prices edged higher on Friday, buoyed by a weaker dollar, but were poised for a weekly decline after hotter-than-expected U.S. producer price data dampened prospects for a super-sized September rate cut by the Federal Reserve. Spot gold rose 0.2% to $3,340.59 per ounce as of 0941 GMT. Bullion has lost 1.7% for the week. U.S. gold futures for December delivery edged up 0.1% to $3,387.50. The U.S. dollar index fell 0.4%, making gold less expensive for other currency holders. "In the short term, gold has a heightened inverse relationship to moves in the U.S. dollar, which in turn is being whipsawed by economic data and fast news on both tariffs and Ukraine," independent analyst Ross Norman said. U.S. producer prices increased by the most in three years in July amid a surge in the costs of goods and services, data showed on Thursday, signaling inflation pressures in the pipeline. Weekly jobless claims also came in lower than expected, at 224,000 compared to forecasts of 228,000. The data dampened bets, fanned by benign consumer price data and comments from U.S. Treasury Secretary Bessent earlier this week, that the Fed's next cut might be more than a quarter-point. Non-yielding gold typically performs well in low-interest-rate environments. U.S. consumer price data showed only a marginal increase in July, briefly boosting hopes for large-size rate cut by the Fed. "We have seen in the past that gold price corrections get smaller and smaller, suggesting that some buyers, who missed out in the past, use these price setbacks as a way to gain exposure to the yellow metal," said UBS commodity analyst Giovanni Staunovo. On the geopolitical front, investors are awaiting the outcome of U.S. President Donald Trump and Russian President Vladimir Putin's meeting in Alaska later in the day. Elsewhere, spot silver fell 0.5% to $37.79 per ounce, platinum lost 0.9% to $1,345.02, and palladium was down 1.2% to $1,131.56. (Reporting by Anmol Choubey in Bengaluru; Editing by Joe Bavier and Christina Fincher)
